Profil
Rachael Z.
Easton is Senior Vice President-Clinical Development at Cogent Biosciences, Inc. since 2022.
Former roles include Sr. Medical Director-Oncology Clinical Development at GSK Plc and Chief Financial Officer & Treasurer at Gladstone Investment Corp.
Education includes undergraduate studies at Washington & Lee University and a doctorate from Washington University School of Medicine.
Postes actifs de Rachael Easton
| Sociétés | Poste | Début |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Corporate Officer/Principal | 28/11/2022 |
Anciens postes connus de Rachael Easton
| Sociétés | Poste | Fin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
| GLADSTONE INVESTMENT CORPORATION | Directeur Financier/CFO | - |
Formation de Rachael Easton
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Gladstone Investment Corp.
Gladstone Investment Corp. Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
Cogent Biosciences, Inc.
Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Washington & Lee University
Washington & Lee University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington University School of Medicine
Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















